This announcement is a separate document:
关于奥锐特药业股份有限公司向不特定对象发行可转换公司债券上市审核委员会会议意见落实函回复报告（2023年年度财务数据更新版）
Response Report on the Implementation Letter of Opinions of the Listing Review Committee Meeting on the Issuance of Convertible Corporate Bonds by Orient Pharmaceutical Co., Ltd. to Unspecified Targets (2023 Financial Data Update)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.